Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 18(11): 2544-2553.e6, 2020 10.
Article
en En
| MEDLINE
| ID: mdl-32621971
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Hepatitis C
/
Hepatitis C Crónica
Tipo de estudio:
Systematic_reviews
Límite:
Humans
/
Middle aged
Idioma:
En
Año:
2020
Tipo del documento:
Article